Takahasi Hitoshi, Fukunishi Masatoshi, Ibaraki Yasuhiko, Fukuda Shota, Shimada Yoshihisa, Kihara Hajime
Division of Laboratory, Kihara Circ. Clinic, Hokkaido 078-8214.
Rinsho Byori. 2003 Mar;51(3):274-7.
Echocardiography was routinely used in evaluating patients with cardiac myxoma, reflecting the improved capability of this technique to assess morphological findings. Recent studies reported that the immunologic findings, such as CRP(C-reactive protein) and IL-6(interleukin-6), were related to the clinical features in patients with cardiac myxoma. Therefore, the purpose of this study was to clarify whether the morphological findings were related to the immunologic and pathologic results in patients with cardiac myxoma. We studied 6 patients (2 men; mean age +/- SD, 62.5 +/- 10.4 years) with cardiac myxoma. Transthoracic and transesophageal echocardiography were used to assess morphological findings. All patients had not symptoms associated with obstruction of the intracardiac blood flow. Five of these 6 patients with increased levels of IL-6 had clinical features. In conclusion, assessment of morphological findings by echocardiography has the potential to infer the immunologic and pathologic results in patients with cardiac myxoma.
超声心动图常用于评估心脏黏液瘤患者，这反映了该技术在评估形态学表现方面能力的提高。最近的研究报告称，免疫指标，如C反应蛋白（CRP）和白细胞介素-6（IL-6），与心脏黏液瘤患者的临床特征相关。因此，本研究的目的是阐明心脏黏液瘤患者的形态学表现是否与免疫和病理结果相关。我们研究了6例（2例男性；平均年龄±标准差，62.5±10.4岁）心脏黏液瘤患者。经胸和经食管超声心动图用于评估形态学表现。所有患者均无与心内血流梗阻相关的症状。这6例IL-6水平升高的患者中有5例具有临床特征。总之，通过超声心动图评估形态学表现有可能推断心脏黏液瘤患者的免疫和病理结果。
